166 related articles for article (PubMed ID: 10498391)
21. Carcinogen-DNA adducts as a biomarker for cancer risk.
Rundle A
Mutat Res; 2006 Aug; 600(1-2):23-36. PubMed ID: 16824556
[TBL] [Abstract][Full Text] [Related]
22. Risk assessment of DNA-reactive carcinogens in food.
Jeffrey AM; Williams GM
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):628-35. PubMed ID: 15990138
[TBL] [Abstract][Full Text] [Related]
23. Development of a monoclonal antibody recognizing benzo[c]phenanthrenediol epoxide-DNA adducts: application to immunohistochemical detection of DNA damage.
Zhang YJ; Geacintov NE; Santella RM
Chem Res Toxicol; 1997 Sep; 10(9):948-52. PubMed ID: 9305575
[TBL] [Abstract][Full Text] [Related]
24. Biological relevance of adduct detection to the chemoprevention of cancer.
Sharma RA; Farmer PB
Clin Cancer Res; 2004 Aug; 10(15):4901-12. PubMed ID: 15297390
[TBL] [Abstract][Full Text] [Related]
25. A possible role for dihydrodiol dehydrogenase in the formation of benzo[a]pyrene-DNA adducts in lung cancer cells and tumor tissues.
Cheng YW; Tsai HJ; Wu JY; Hsu YF; Chen CY; Hao NJ; Lee H
Environ Mol Mutagen; 2007 Jan; 48(1):14-21. PubMed ID: 17163506
[TBL] [Abstract][Full Text] [Related]
26. High DNA damage by benzo[a]pyrene 7,8-diol-9,10-epoxide in bronchial epithelial cells from patients with lung cancer: comparison with lung parenchyma.
Rojas M; Marie B; Vignaud JM; Martinet N; Siat J; Grosdidier G; Cascorbi I; Alexandrov K
Cancer Lett; 2004 Apr; 207(2):157-63. PubMed ID: 15072824
[TBL] [Abstract][Full Text] [Related]
27. Preferential carcinogen-DNA adduct formation at codons 12 and 14 in the human K-ras gene and their possible mechanisms.
Hu W; Feng Z; Tang MS
Biochemistry; 2003 Aug; 42(33):10012-23. PubMed ID: 12924950
[TBL] [Abstract][Full Text] [Related]
28. Detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer.
Zhu J; Chang P; Bondy ML; Sahin AA; Singletary SE; Takahashi S; Shirai T; Li D
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):830-7. PubMed ID: 14504191
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, characterization, and 32P-postlabeling of N-(deoxyguanosin)-4-aminobiphenyl 3'-phosphate adducts.
Haack T; Boche G; Kliem C; Wiessler M; Albert D; Schmeiser HH
Chem Res Toxicol; 2004 Jun; 17(6):776-84. PubMed ID: 15206898
[TBL] [Abstract][Full Text] [Related]
30. High-affinity monoclonal antibodies for the specific recognition and quantification of deoxynucleosides structurally modified by N-nitroso compounds.
Adamkiewicz J; Ahrens O; Huh N; Nehls P; Rajewsky MF; Spiess E
IARC Sci Publ; 1984; (57):581-7. PubMed ID: 6533050
[TBL] [Abstract][Full Text] [Related]
31. DNA adduct burden and tobacco carcinogenesis.
Wiencke JK
Oncogene; 2002 Oct; 21(48):7376-91. PubMed ID: 12379880
[TBL] [Abstract][Full Text] [Related]
32. Search of anti-adriamycin antibodies in serum of cancer patients under chemotherapic treatment.
Verdina A; Tonachella R; Colella E; Falasca G; Galati R
J Exp Clin Cancer Res; 2002 Sep; 21(3):337-40. PubMed ID: 12385574
[TBL] [Abstract][Full Text] [Related]
33. Cancer risk assessment for crotonaldehyde and 2-hexenal: an approach.
Eder E; Schuler D; Budiawan
IARC Sci Publ; 1999; (150):219-32. PubMed ID: 10626223
[TBL] [Abstract][Full Text] [Related]
34. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
Pavanello S; Clonfero E
G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
[TBL] [Abstract][Full Text] [Related]
35. Methods for testing compounds for DNA adduct formation.
Reddy MV
Regul Toxicol Pharmacol; 2000 Dec; 32(3):256-63. PubMed ID: 11162719
[TBL] [Abstract][Full Text] [Related]
36. Detection of 1,N6-etheno-2'-deoxyadenosine and 3,N4-etheno-2'-deoxycytidine occurring endogenously in DNA.
Watson WP; Aston JP; Barlow T; Crane AE; Potter D; Brown T
IARC Sci Publ; 1999; (150):63-73. PubMed ID: 10626209
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the DNA damaging potential of cannabis cigarette smoke by the determination of acetaldehyde derived N2-ethyl-2'-deoxyguanosine adducts.
Singh R; Sandhu J; Kaur B; Juren T; Steward WP; Segerbäck D; Farmer PB
Chem Res Toxicol; 2009 Jun; 22(6):1181-8. PubMed ID: 19449825
[TBL] [Abstract][Full Text] [Related]
38. The 32P-postlabeling assay for DNA adducts.
Phillips DH; Arlt VM
Nat Protoc; 2007; 2(11):2772-81. PubMed ID: 18007613
[TBL] [Abstract][Full Text] [Related]
39. The effect of humoral immunity against adducted benzo[a]pyrene on DNA damage elicited by acute carcinogen exposure in Swiss mice.
Galati R; Crebelli R; Zijno A; Conti L; Falasca G; Verdina A
In Vivo; 2000; 14(6):747-51. PubMed ID: 11204493
[TBL] [Abstract][Full Text] [Related]
40. Antisera specific for carcinogen-DNA adducts and carcinogen-modified DNA: applications for detection of xenobiotics in biological samples.
Poirier MC
Mutat Res; 1993 Jul; 288(1):31-8. PubMed ID: 7686263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
